A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
about
Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis opticaChange in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary studyAquaporin 4 and neuromyelitis opticaHypersensitivity Responses in the Central Nervous SystemAntibodies as Mediators of Brain PathologyUpdate on biomarkers in neuromyelitis opticaImmunology of neuromyelitis optica: a T cell-B cell collaborationMolecular pathogenesis of neuromyelitis opticaExpanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.Experimental models of neuromyelitis optica.Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.Neuromyelitis optica: an antibody-mediated disorder of the central nervous system.Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier.Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica.Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.Neuromyelitis optica mimicking intramedullary tumor.Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive ratsComplement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.Evaluation of aquaporin-4 antibody assays.MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.Different Phenotypes at Onset in Neuromyelitis Optica Spectrum Disorder Patients with Aquaporin-4 AutoimmunityEFNS guidelines on diagnosis and management of neuromyelitis optica.The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis.Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.Interferons in the central nervous system: a few instruments play many tunes.Pain in neuromyelitis optica--prevalence, pathogenesis and therapy.Neuromyelitis optica: a positive appraisal of seronegative cases.The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination.Th17 cells in neuromyelitis optica spectrum disorder: a review.T cell-activation in neuromyelitis optica lesions plays a role in their formation.Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study.Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G.A case of neuromyelitis optica masquerading as miller fisher syndrome.Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders.Clinical relevance of serum aquaporin-4 antibody levels in neuromyelitis optica.Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica.Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity.
P2860
Q21132530-E3D68D6B-E12F-4C0E-9C33-C89C6778175CQ21558554-D94791D2-835B-4BFF-8C3E-497011758D1EQ24613666-C14FB4BD-0EB1-4E67-8BD8-A5E4066D8CBDQ26779177-3497ED15-7E80-4539-A861-302473E9DEF3Q26780374-AE6360F0-7A86-4A4D-97BB-DEE8FBAE14B9Q26799789-D755321E-0381-45CC-BC3E-B8A0D21B9FC5Q27016045-8AC7CF08-E753-4316-9713-3822505D5645Q27021535-1D521249-177C-454C-8395-02E4B8977110Q33770508-12D046EE-A3A8-474A-805A-C36453B94E7BQ33785380-B44FEA45-0F1C-49BE-B5A4-017209AD7EECQ34529121-1F4B85E7-06BF-4762-881B-8A09639C1A9FQ35738898-71978C1A-3A18-42D7-8E51-3A548FD18A98Q36010441-4650B520-0EAF-4175-9C20-D169465D1AB4Q36323831-08704C05-33E0-4EEE-89F7-3BCEB1D0933DQ36515512-977A7914-C0CE-419B-A820-DFE9C3F9E1C8Q37061002-7CF380B1-A1D6-4BC3-B7AB-C7CF7B558D8FQ37180238-5FDBAEE8-A4BD-4271-AFA6-28B726FEF40EQ37353732-27A8496D-9679-4E35-966B-EE62E1B647B5Q37383555-2127C59D-CB93-42A6-ACDD-B7B318D1BFD4Q37404328-B8D9F312-2022-4444-A523-32A455F94655Q37590294-87F058B0-B948-412A-9C7B-DFB60246FB9FQ37670455-B7DE87A1-1176-47DA-BFE0-DCA0FB70C58BQ37763266-0492B26A-AB10-4438-A2DD-2850CD5AE420Q37849770-8AEF9B82-B80E-4ABA-A5DE-CC925AE5C00FQ38151920-FD51D9A0-4D90-4E56-AFAD-3397FC2D9219Q38192651-384E1C31-5A42-469D-80E3-426A2464FB39Q38235026-B193BD37-BCAA-4724-982F-96D66FE3A269Q38358675-7EF062E3-3B2E-4F8A-977F-53D8E129791FQ38714054-4D3D3558-12C5-4988-985F-BA38223988B4Q38765404-D7CBB4B9-F460-4A08-AC80-232C598FB4AEQ39039987-EF7DAD69-F55D-4796-96A2-2800A562DBAFQ39785941-E98582FE-F9C5-41CB-96C9-82B257FEFBD1Q41163269-7454DAC9-61CD-4BA1-8859-51E285383617Q41656432-E3312E1A-D086-4FD4-AB08-FD26BEC4B231Q41831300-BA105636-FC48-423D-A1C9-49E672A76E19Q42560864-BB41837C-ACD4-43D1-A293-C2B3352BD490Q43067194-B59CCE88-7DB8-4D24-84E9-2BF1D63295C8Q43450168-9A7824FD-D13A-4F2C-AAE3-8E8B1CF3177FQ47926002-1082885F-16D3-4E86-9CF2-3FA1EA0BF366Q48100298-79D74F7F-1011-463A-97C9-313270CD4301
P2860
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
@ast
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
@en
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
@nl
type
label
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
@ast
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
@en
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
@nl
prefLabel
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
@ast
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
@en
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
@nl
P2093
P3181
P1433
P1476
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
@en
P2093
K Fujihara
S Nishiyama
T Takahashi
P304
P3181
P356
10.1212/WNL.0B013E3181A82621
P407
P577
2009-06-02T00:00:00Z